260 related articles for article (PubMed ID: 31216201)
1. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
2. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
[TBL] [Abstract][Full Text] [Related]
5. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.
Hassanzadeh E; Alessandrino F; Olubiyi OI; Glazer DI; Mulkern RV; Fedorov A; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2018 May; 43(5):1237-1244. PubMed ID: 28840280
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
7. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
[TBL] [Abstract][Full Text] [Related]
8. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
10. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
11. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.
Lebovici A; Sfrangeu SA; Feier D; Caraiani C; Lucan C; Suciu M; Elec F; Iacob G; Buruian M
BMC Med Imaging; 2014 May; 14():15. PubMed ID: 24885552
[TBL] [Abstract][Full Text] [Related]
13. Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score.
Jyoti R; Jain TP; Haxhimolla H; Liddell H; Barrett SE
Eur J Radiol Open; 2018; 5():58-63. PubMed ID: 29687050
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
[TBL] [Abstract][Full Text] [Related]
17. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
18. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging.
Raczeck P; Frenzel F; Woerner T; Graeber S; Bohle RM; Ziegler G; Buecker A; Schneider GK
Invest Radiol; 2022 Apr; 57(4):233-241. PubMed ID: 34743133
[TBL] [Abstract][Full Text] [Related]
19. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
Woo S; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]